What is the ticker symbol for ABVC BioPharma?

ABVC BioPharma trades under the ticker ABVC on NASDAQ.

What sector does ABVC BioPharma operate in?

ABVC BioPharma is classified in the Healthcare sector (Biotechnology industry).

How can PortView help analyze ABVC in a portfolio?

PortView shows ABVC's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

ABVC BioPharma (ABVC) Stock Analysis

NASDAQHealthcareBiotechnology

$0.84+1.89%

1-year price historyRange $0.71 – $3.29

52-week range$0.84

$0.71$3.40

What ABVC BioPharma does

ABVC BioPharma, Inc. is a clinical-stage biopharmaceutical company focused on creating novel drugs and medical devices to address critical, underserved healthcare requirements across the United States. The company's pipeline includes several key candidates: ABV-1501, currently undergoing Phase I/II clinical trials, is being developed as a combination treatment for triple-negative breast cancer. ABV-1504 has successfully completed Phase II clinical trials for major depressive disorders. ABV-1505 is progressing through Phase II clinical studies for attention deficit hyperactivity disorder (ADHD). ABV-1703 has concluded its Phase I clinical trials for the treatment of pancreatic cancer. ABV-1702 has also finished Phase I clinical investigations for myelodysplastic syndromes. ABV-1601 is in Phase I/II clinical trials, aimed at alleviating depression in individuals with cancer. ABV-1701 Vitargus is in development to treat conditions such as retinal detachment or vitreous hemorrhage. ABVC BioPharma maintains strategic alliances, including a co-development arrangement with Rgene Corporation, alongside collaborative agreements with BioHopeKing Corporation and BioFirst Corporation. The company's headquarters are located in Fremont, California, and it operates as a subsidiary of YuanGene Corporation.

Key metrics

Market cap

$21.87M

P/E (TTM)

-2.34

EPS (TTM)

$-0.36

Beta

0.54

Dividend yield

0.00%

Revenue / share

$-0.03

50-day avg

$1.18

200-day avg

$1.54

52-week high

$3.40

52-week low

$0.71

CEO

Uttam Yashwant Patil

ETFs linked to ABVC

Broad-market and Healthcare sector ETFs an investor holding ABVC BioPharma is often also exposed to. Open an ETF page to see its actual top holdings.

SPY — SPDR S&P 500 ETF Trust VOO — Vanguard S&P 500 ETF QQQ — Invesco QQQ Trust VTI — Vanguard Total Stock Market ETF

PortView Portfolio Insights

PortView analyzes how ABVC fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Analyze ABVC in PortView →

Similar companies

JNJ — Johnson &LLY — Eli Lilly A — Agilent Technologies ABBV — AbbVie Inc.ABT — Abbott Laboratories ALNY — Alnylam Pharmaceuticals

Frequently asked questions

What is the ticker symbol for ABVC BioPharma?: ABVC BioPharma trades under the ticker ABVC on NASDAQ.
Which exchange is ABVC listed on?: ABVC is listed on NASDAQ.
What sector does ABVC BioPharma operate in?: ABVC BioPharma is classified in the Healthcare sector (Biotechnology industry).
How can PortView help analyze ABVC in a portfolio?: PortView shows ABVC's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.